Company Filing History:
Years Active: 2023
Title: Helen M Thackray: Innovator in Cancer Treatment
Introduction
Helen M Thackray is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of cancer treatment, particularly in methods for treating acute myeloid leukemia (AML) and related conditions. Her innovative work has the potential to impact many lives.
Latest Patents
Helen M Thackray holds 1 patent for her invention titled "Methods for treating acute myeloid leukemia and related conditions." This patent describes methods for treating or inhibiting cancer and/or one or more related conditions by administering to a subject in need thereof an effective amount of a compound of Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of any of the foregoing. The methods include treating AML, myelodysplastic syndromes (MDS), neutropenia, and/or mucositis by administering a pharmaceutical composition comprising a compound of Formula (I).
Career Highlights
Helen is associated with Glycomimetics, Inc., where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Helen has collaborated with notable colleagues such as Henry H Flanner and Curt D Wolfgang. These partnerships have likely contributed to the success of her innovative projects and research initiatives.
Conclusion
Helen M Thackray is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. Her contributions are vital in the quest for effective therapies against challenging diseases.